SCHEMBL20161754

SCHEMBL20161754

CC(C)NC1CCN(C)CCC1C

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
NCF1 P14598 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13610240 0.86 NCF1 (0.30) NCF1
SCHEMBL24467166 0.86 SSTR4 (0.35) NCF1
SCHEMBL20161749 0.86 SSTR4 (0.35) NCF1
SCHEMBL25033580 0.86 SSTR4 (0.35) NCF1
SCHEMBL23365921 0.82 KDM1A (0.34)
SCHEMBL23365998 0.82 KDM1A (0.34)
SCHEMBL23366013 0.76
SCHEMBL14268028 0.75 TAS1R3 (0.40)
SCHEMBL18412740 0.75 TAS1R3 (0.40)
SCHEMBL10130312 0.75 TAS1R3 (0.44)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018089261-A2 COMPOUNDS AND METHODS FOR MODULATING INTERLEUKIN-2-INDUCIBLE T-CELL KINASE CORVUS PHARMACEUTICALS, INC. (US) 2018-05-17 WO disclosed